期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 891, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2020.173683
关键词
Morphine; Myocardial ischaemia-reperfusion; Chronic heart failure; ST segment Elevation myocardial infarction
Coronary heart disease is a common cardiovascular disease that can lead to heart failure due to myocardial injury caused by ischaemia-reperfusion. Morphine, a nonselective opioid receptor agonist, has potential cardiac protective effects. This review mainly focuses on the role of morphine in animal models and patients with heart disease.
Coronary heart disease (CHD) is a cardiovascular disease with high mortality and disability worldwide. The main pathological manifestation of CHD is myocardial injury due to ischaemia-reperfusion, resulting in the death of cardiomyocytes (apoptosis and necrosis) and the occurrence of cardiac failure. Morphine is a nonselective opioid receptor agonist that has been commonly used for analgesia and to treat ischaemic heart disease. The present review focused on morphine-induced protection in an animal model of myocardial ischaemia-reperfusion and chronic heart failure and the effects of morphine on ST segment elevation myocardial infarction (STEMI) patients who underwent pre-primary percutaneous coronary intervention (pre-PPCI) or PPCI. The signalling pathways involved are also briefly described.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据